Swiss Growth Forum Welcomes you to Exclusive Monaco and EU Summer Events Co-Hosted by Michael Terpin July 4th - 9th forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
(2)
Webcast registration link appears below
Andreea Porcelli, CEO of Swiss Growth Forum, will be a co-presenter on the webcast in her separate capacity as a sponsor of the proposed SPAC
Andreea Porcelli and Jaguar CEO Lisa Conte interviewed again on Innovators with Jane King
SAN FRANCISCO, CA / ACCESSWIRE / January 26, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ( Jaguar or the Company ) issued a reminder today that the Company and a sponsor of the proposed Post Pandemic Recovery special purpose acquisition company ( the SPAC ) are hosting a webcast on Wednesday, January 27, 2021 at 8:30 AM Eastern Time to provide updates regarding the potential merger of Napo EU, an anticipated subsidiary of the Company in Italy, with the SPAC. Andreea Porcelli, in her capacity as a sponsor of the SPAC, will be a co-presenter on the webcast along with Lisa Conte, Jaguar s founder, president, and CEO. Porcelli is also the CEO of Swiss Growth Forum.
Webcast registration link appears below Andreea Porcelli, CEO of Swiss Growth Forum, will be a co-presenter on the webcast in her separate capacity as a sponsor of the proposed SPAC Andreea Porcelli
January 12, 2021
Jaguar Health (NASDAQ:
JAGX) wasn’t a common topic of conversation prior to December 2020. However, breathtaking price moves have recently put JAGX stock in the limelight, practically forcing healthcare sector traders to take notice.
Source: Bukhta Yurii / Shutterstock.com
Yet, these are not your run-of-the-mill medical treatment options. The company’s wholly owned subsidiary, Napo Pharmaceuticals, develops and commercializes treatments based on rainforest-area plants.
Is this a niche market worth pursuing? A glance at the price action of JAGX stock should answer that question. Just suffice it to say that the company and the stock are moving quickly and making the short sellers run for the hills.
Why Jaguar Health Stock Skyrocketed 49% Today Joe Tenebruso
What happened
Shares of
Jaguar Health (NASDAQ: JAGX) soared 49.3% on Friday, extending the pharmaceutical company s staggering gains since mid-November.
So what
Jaguar Health s stock price is up a stunning 2,062% since its lows on Nov. 16. Investors have bid up the healthcare stock after management announced its plan to develop and commercialize crofelemer, a new drug aimed at helping people with inflammatory diarrhea, including those who have recovered from COVID-19 but are still experiencing symptoms.
Jaguar Health said the plan could involve a potential merger of its operating subsidiary with Swiss Growth Forum, a sponsor of a special purpose acquisition company (SPAC). Preliminary terms of the deal include Jaguar Health receiving upfront cash payments of as much as $10 million and at least $20 million in clinical development funding, as well as an equity stake in the new company of 30% to 4